Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
Cancers|February 6, 2021
Prognostic Value of 5-ALA Fluorescence, Tumor Cell Infiltration and Angiogenesis in the Peritumoral Brain Tissue of Brain MetastasesPetra A Mercea, Mario Mischkulnig, Barbara Kiesel, et al.
Biomedical Optics Express|March 25, 2020
Towards real-time wide-field fluorescence lifetime imaging of 5-ALA labeled brain tumors with multi-tap CMOS camerasDavid Reichert, Mikael T Erkkilä, Gerhard Holst, et al.
Neuroimage|February 18, 2019
High-resolution metabolic mapping of gliomas via patch-based super-resolution magnetic resonance spectroscopic imaging at 7TGilbert Hangel, Saurabh Jain, Elisabeth Springer, et al.
Frontiers in Oncology|October 1, 2021
Fluorescence Lifetime Imaging and Spectroscopic Co-Validation for Protoporphyrin IX-Guided Tumor Visualization in NeurosurgeryDavid Reichert, Mikael T Erkkilae, Johanna Gesperger, et al.
Radiology. Imaging Cancer|September 12, 2025
High-Resolution Mapping of Tumor and Peritumoral Glutamate and Glutamine in Gliomas Using 7-T MRSIGilbert Hangel, Philipp Lazen, Cornelius Cadrien, et al.
Cancers|March 13, 2024
A Comparison of 7 Tesla MR Spectroscopic Imaging and 3 Tesla MR Fingerprinting for Tumor Localization in Glioma PatientsPhilipp Lazen, Pedro Lima Cardoso, Sukrit Sharma, et al.
Epilepsia|January 5, 2026
A novel PTEN variant causing hemimegalencephaly and focal nodular heterotopias in the developing human brainFranziska Fazekas, Amit Haboosheh, Bernhard Hennebichler, et al.
Journal of Neurointerventional Surgery|September 28, 2019
Evaluation of the radiosurgical treatment of cerebral arteriovenous malformations: a retrospective single-center analysis of three decadesDorian Hirschmann, Philipp Goebl, Frederic H Witte, et al.
Frontiers in Oncology|March 9, 2023
Flavin fluorescence lifetime and autofluorescence optical redox ratio for improved visualization and classification of brain tumorsDavid Reichert, Lisa I Wadiura, Mikael T Erkkilae, et al.
Cancers|June 2, 2021
5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)-Experience at Two Specialized CentersArthur Hosmann, Matthias Millesi, Lisa I Wadiura, et al.
Pageof 7